Introduction. Crimean-Congo haemorrhagic fever (CCHF) is an acute viral haemorrhagic disease. Reactive oxygen species that are mainly generated by the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) enzyme family have a pivotal role in the pathophysiology of many diseases. The serum levels of NOX isoforms in patients with CCHF have yet to be assessed.
INTRODUCTION
Crimean-Congo haemorrhagic fever (CCHF) is an acute viral haemorrhagic disease with a mortality rate of between 4 and 30 % [1] . The virus that causes CCHF belongs to the genus Nairovirus of the family Bunyaviridae [2] . CCHF has different non-specific symptoms, such as fever, muscle pain, dizziness, abnormal sensitivity to light, abdominal pain and vomiting [2] [3] [4] [5] . The main clinical abnormality is haemorrhage due to an increase in vascular permeability. Replication of the virus, pro-inflammatory response, endothelial damage, activation of the intrinsic coagulation cascade, dissemination of intravascular coagulation and multi-organ failure also contribute to the emergence of clinical abnormalities [4] [5] [6] [7] .
Reactive oxygen species (ROS) that are mainly generated by the NADPH oxidase (NOX) enzyme family have a pivotal role in the pathophysiology of many diseases [8] . The nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) family consists of seven catalytic homologues. Endothelial cells express the four NOX isoforms, NOX-1, NOX-2, NOX-4 and NOX-5 [9] [10] [11] . All of these enzymes use NADPH as an electron donor and these electrons are transferred by NOX to molecular oxygen to form superoxide and hydrogen peroxide, which are ROS. The physiological functions of NOX family enzymes include the modulation of the redox-sensitive signal pathway, which is related with cell growth, differentiation, migration and proliferation [12] . NOX isoforms have also been implicated in the pathogenesis of different viral diseases, including hepatitis C virus (HCV) infection [13] [14] [15] and influenza A virusrelated lung inflammation [16] . Boudreau et al. found that HCV-induced NOX-4 expression induced ROS production, while it may also be related to HCV-associated liver disease [15] . However, to the best of our knowledge, there has been no study on serum levels of NOX isoforms in patients with CCHF.
In the present study, we determined the changes of serum levels of NOX-1, NOX-2, NOX-4 and NOX-5 in CCHF patients and explored the relationship between NOX, thrombocyte suspension and fresh frozen plasma (FFP) treatment. Finally, we investigated the performance of serum NOX for the diagnosis of CCHF.
METHODS

Patients and controls
This prospective study was conducted in Cumhuriyet University, Turkey. Only patients with CCHF confirmed by the National Reference Virology Laboratory at Refik Saydam National Hygiene Center in Ankara, Turkey were enrolled in the study. CCHF was confirmed by the presence of CCHFV RNA in the blood, as determined by reverse transcriptase-polymerase chain reaction and/or the detection of specific IgM using an enzyme-linked immunosorbent assay (ELISA). The study subjects comprised 67 CCHF patients [39 males and 28 females; 18-82 years old (mean age: 51 ±17 years)] and 70 healthy control subjects [40 males and 30 females; 18-76 years old (mean age: 50±14 years)]. A total of 67 clinical samples collected from December 2015 to 2016 were evaluated. Records were obtained from Cumhuriyet University Hospital's laboratory information system to determine age and gender, and the alanine aminotransferase (ALT), blood urea nitrogen (BUN), creatinine, total bilirubin, direct bilirubin, lactate dehydrogenase (LDH), international normalization ratio (INR), aspartate aminotransferase (AST), prothrombin time (PT), platelet, activated partial thromboplastin time (aPTT), haemoglobin (Hb), fibrinogen, white blood count (WBC), thrombocyte and C-reactive protein (CRP) values. To date, two different severity scores have been described by Bakır et al. [17] and Dokuzoguz et al. [18] . According to the two different scores, the patients were classified as low or intermediate-high mortality risk groups on admission, and they were then compared with each other in terms of serum NOX levels. The exclusion criteria for the control group included clinical suspicion of infection and the presence of liver disease, kidney disease, diabetes mellitus, alcohol consumption, rheumatic disease, malignancy, pregnancy and smoking. The protocol was approved by the Ethics Committee of Cumhuriyet University (2015-12/03).
Samples and biochemical analysis
Overnight fasting blood samples were collected from all participants into red top tubes (Becton Dickinson, UK). Samples were taken on the day of admission to the hospital. The serum sample tubes were allowed to clot before centrifugation. After centrifugation at 4 C for 15 min at 3500 r.p.m., the serum was aliquoted and immediately frozen at À40 C. The quantitative sandwich ELISA technique was used for the determination of serum NOX-2 (LZ biotech) NOX-1, NOX-4 and NOX-5 (Elabscience). The tests were performed according to the manufacturer's recommendations. The intra-assay and inter-assay coefficients of variation were <10 % and <12 %, respectively. Complete blood count analysis was performed using the haematology system (Mindray BC6800). Fasting total bilirubin, direct bilirubin, creatinine, BUN, LDH, INR, ALT and AST values were determined using the enzymatic colorimetric method (Beckman Coulter AU5800, USA). PT, aPTT, INR and fibrinogen measurements were made using a haemostasis analyzer system (ACL TOP 700). The serum CRP levels were measured using nephelometry (Beckman Coulter).
Statistical analysis
Data normality was evaluated using the histogram method, q-q graphs and the Shapiro-Wilk test. The Mann-Whitney U test was applied for quantitative variables in betweengroup comparisons. The correlation between quantitative data was assessed with the Spearman test. The discriminative performance of NOX levels was assessed with receiver operating characteristic (ROC) curves. The areas under the ROC curves were calculated with 95 % confidence intervals and compared with each other. Cutoff values were determined for each NOX marker using the Youden index. Statistical diagnostic measurements, including sensitivity, specificity, and positive and negative predictive values, were calculated with 95 % confidence intervals. Hazard ratios were calculated with 95 % confidence intervals to indicate the survival risk for NOX levels in patients. Data analysis was conducted using R.3.2.1 (www.r-project.org) and easy ROC software. A value of P<0.05 was considered statistically significant.
RESULTS
The median NOX-1 levels were 43.5 (33.1-51.4) and 32.6 (10.8-48.4) ng ml À1 in the patients and controls, respectively (P=0.001). The median NOX-5 levels were 2792 (2583.9-3176.1) and 306 (254.5-354.3) pg ml À1 in the patients and controls, respectively (P<0.001). The differences in terms of NOX-2 and NOX-4 were not statistically significant between the patient and control groups. The results of the comparisons of serum NOX levels between the control and patient groups are shown in Table 1 . Higher median serum NOX-5 levels were determined in the low-grade disease group compared to Values are expressed as median (first to third quartiles).
the intermediate-high disease group according to the two different severity scores (Tables 2 and 3) . A negative correlation was determined between the serum NOX-5 levels, the Bakır severity score (P<0.05, r=-0.259), the Dokuzoguz severity score (P<0.01, r=À0.417) and the aPTT levels (P<0.05, r=-0.306) in patients. A positive correlation was found between the serum NOX-5 levels and the thrombocyte counts (P<0.01, r=0.342). The Spearman correlation coefficients between the NOX levels and other laboratory parameters are presented in Table 4 . Receiving operating characteristic analyses were applied for NOX-1, NOX-2, NOX-4 and NOX-5 variables, and the AUC values were found to be 0.67 ( (Table 5) . Platelet suspension and fresh frozen plasma (FFP) were given as supportive care in 24 and 33 patients, respectively. To determine the patients who needed platelet and FFP suspensions, the criteria given in the study by Leblebicioglu et al. [19] were used. The mean platelet counts were 13.000 mm À3 in patients who needed the thrombocyte suspension. The NOX levels were measured in patients with or without treatment by thrombocyte suspension and FFP. Blood samples were obtained from patients receiving platelet suspension and FFP before the administration of the platelet suspension and plasma. The mean NOX-5 levels were 2617.9 (1557.2-3018.0) and 2922.3 (2736.5-3239.9) pg ml À1 (P=0.004) in patients with or without treatment by thrombocyte suspension. There were no significant difference in terms of NOX-1 (P=0.505), NOX-2 (P=0.583) and NOX-4 (P=0.343) between patients with or without treatment by thrombocyte suspension. There were also no significant changes between patients with or without treatment by FFP in terms of serum NOX levels. Comparisons of the NOX levels between the CCHF patients with or without treatment by thrombocyte suspension and FFP are shown in Tables 6 and 7 , respectively.
DISCUSSION
The role of NOX has been examined in previous animal studies [16, 19, 20] . Vlahos et al. showed that NOX-2 inhibitors had therapeutic potential for the control of lung inflammation associated with influenza in mice [16] . Hernandes et al. demonstrated the relationship between NOX-2 derived ROS production and oxidative damage to the hippocampus in mice with sepsis-associated encephalopathy [20] . Hofstetter et al. found that NOX-1 modulates the innate and adaptive immune response in experimental influenza A virus infection [21] . In the current study, the levels of NOX-1 and NOX-5 were found to be higher in patients than in the control group, but no difference was determined between the Results are expressed as median (first to third quartiles) with 95 % confidence interval. Results are expressed as median (first to third quartiles) with 95 % confidence interval. patient and control groups in terms of median NOX-2 and NOX-4 levels. The differences between studies might be related to differences in the experimental systems and disease characteristics. To the best of our knowledge, the data obtained in this study provide the first finding of increased NOX levels in CCHF patients. Several studies have reported increased levels of blood oxidative stress markers such as total oxidant status and total thiol and nitric oxide in patients with CCHF [22] [23] [24] . NOX-1 and NOX-5 are the major contributors to ROS production, including superoxide anions (O 2 -), hydroperoxyl radicals and hydroxyl radicals, in the body. The current study results seem to be concordant with earlier findings that have shown increased levels of ROS production in CCHF patients [22] [23] [24] . Therefore, it can be considered that upregulated serum NOX-5 and NOX-1 expression contributes to the increased level of ROS in CCHF patients.
The role of platelets in the NOX expression has been demonstrated in two different reports [25, 26] . Bartimoccia et al. found NOX-5 expression in platelets from patients with chronic granulomatous disease [25] . Seno et al. demonstrated the expression of p22(phox) and p67(phox), which are components of NOX in platelets [26] . NOX-derived ROS have an important impact on platelet function. It has been shown that NOX-associated platelet O 2 -formation enhances platelet aggregation and platelet-dependent thrombosis [27, 28] . In the current study, a positive correlation was determined between serum NOX-5 levels and platelet counts, and a negative correlation was found between NOX-5 values and aPTT. The serum NOX-5 level was found to be lower in patients who required platelet suspension compared to those with no requirement, and a negative correlation was determined between the NOX-5 levels and the two severity scores.
Decreased platelet counts and platelet aggregation have a pivotal role in viral haemorrhagic fevers [29] . In addition, the production of ROS that are mainly produced by the activity of NOX may act as a host defence mechanism to influence the replication of the viruses [30] . Olagnier et al. found associations between NOX-dependent ROS production and antiviral activity in Dengue infection [31] . Therefore, the serum levels of NOX-5 can be considered to contribute to the antiviral activity in CCHF.
Although the gold standard for the diagnosis of CCHF is virus isolation, it cannot be used in routine laboratory tests because of the need for biosafety level 4. Therefore, many laboratories use IgM and IgG ELISA and/or RT-PCR to determine the presence or absence of CCHFV infection. The test sensitivities of these tests have been reported as 87.8-93.9 %, 80.4-86.1% and 79.6-83.3 %, respectively [32] . The area under the curve (AUC) for NOX-5 in the current study was found to be 0.99, with 0.94 sensitivity and 1.0 specificity above >1363.4 pg ml À1 . Higher negative [0.94 (confidence interval: 0.86-1.00)] and positive predictive values [1.00 (confidence interval: 0.94-1.00)] were also determined for NOX-5. The sensitivity of NOX-5 was found to be higher compared to the aforementioned methods. Therefore, it can be considered that serum NOX-5 levels could be used as a novel biomarker in the diagnosis of CCHF with a cutoff value of >1363.4 pg ml
À1
.
In conclusion, this study evaluated changes in the serum NOX in CCHF patients. The increased serum expressions of NOX-1 and NOX-5 may contribute to the molecular mechanism of ROS production in CCHF patients. A relationship was observed between disease severity and NOX-5 levels, and NOX-5 was also seen to contribute to the antiviral activity in CCHF patients. Finally, the measurement of serum NOX-5 levels may be used as a novel biochemical test in the diagnosis of CCHF. Further research is needed to confirm these findings and examine possible explanations.
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